New drugs for MS patients

In the past year, patients with relapsing forms of multiple sclerosis (MS) have gotten three new treatment options. Mavenclad (cladribine) is the most groundbreaking of the new drugs, in my opinion, due to its unique […]

View more

One-year results of LAANTERN epilepsy study show seizure improvements

A new study published in Epilepsy Research found 64.3% of patients with various forms of drug-resistant epilepsy in the LAANTERN (Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System) registry were free of disabling […]

View more

How improving door-to-needle time saves lives

When a suspected stroke patient comes into the hospital, everyone on the team has assigned roles so care is delivered quickly and efficiently — picture a race car pit crew jumping over the railing to […]

View more

Study shows cluster headache medication can have long-term benefits

A drug used to relieve a cluster headache cycle also can help with subsequent cycles if patients continue the therapy, according to a new study by Norton Neuroscience Institute neurologist Brian M. Plato, D.O. Episodic […]

View more

Neuroscience Updates: ‘Migraine management and treatment options’

Join us Tuesday, Sept. 15, for a lunchtime series providing the latest updates in neuroscience. This program will be livestreamed from noon to 1 p.m. Mandy Whitt, M.D., headache specialist with Norton Neuroscience Institute, will […]

View more

Norton Brownsboro Hospital expansion opens

The expansion of Norton Brownsboro Hospital is complete, with 70 new patient beds — a 55% increase — advancements in stroke and aneurysm care capabilities and a larger emergency department. The new emergency department has […]

View more

When to make a specialty referral for a headache patient

Headache disorders, by nature, can be difficult to diagnose and treat. When providers are uncomfortable with the diagnosis or feel the patient may need additional treatments with which they aren’t as familiar, it’s best to […]

View more

Sharp drop seen in stroke patients may indicate ignored transient ischemic attacks

The number of patients seeking stroke treatment at Norton Healthcare has been falling sharply since the COVID-19 outbreak began its sweep across the United States in March. In May, 36% fewer patients sought stroke care […]

View more

Teen recalls sister’s epilepsy care with child neurologist Vinay Puri, M.D.

By Sydney Badon Seven years ago, my younger sister, Samantha, was diagnosed with epilepsy. Who would have thought that fluttering her eyes was actually a seizure? Sam didn’t seem herself, and so our pediatrician ordered […]

View more

Patients with epilepsy are at high risk for depression

In a study of adults, researchers found that those with epilepsy were twice as likely as adults without epilepsy to report feelings of depression in the previous year. Depressive thoughts or feelings can result from […]

View more

Louisville neurosurgeon named among ‘20 People to Know in Health Care’

David A. Sun, M.D., PhD., neurosurgeon and executive medical director of Norton Neuroscience Institute has been named among Louisville Business First’s 20 People to Know in Health Care. Dr. Sun, who also is the co-director […]

View more

Norton Neuroscience Institute recognized as multiple sclerosis leader

The National Multiple Sclerosis Society has presented Norton Neuroscience Institute with its 2019 Leadership award. Norton Healthcare received the honor for its continued commitment and dedication to treating those living with MS. “The team at […]

View more

Search our entire site.